Andy Göbel

3PUBLICATIONS
0CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 31, 2020
Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer.

Andy Göbel, Valentina M Zinna, Stefania Dell'Endice

|Feb 11, 2020
High serum levels of periostin are associated with a poor survival in breast cancer.

Tilman D Rachner, Andy Göbel, Oliver Hoffmann

|May 21, 2017
Adjuvant tamoxifen but not aromatase inhibitor therapy decreases serum levels of the Wnt inhibitor dickkopf-1 while not affecting sclerostin in breast cancer patients.

Andy Göbel, Jan D Kuhlmann, Theresa Link

Pageof 1

Frequent Collaborators